Belvedere Trading LLC Tricida, Inc. Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 21, 2022
SELL
$7.31 - $11.85 $87,222 - $141,394
-11,932 Reduced 52.18%
10,935 $104,000
Q1 2022

Apr 20, 2022
BUY
$7.35 - $10.63 $127,662 - $184,632
17,369 Added 315.91%
22,867 $269,000
Q4 2021

Jan 25, 2022
BUY
$4.19 - $9.56 $23,036 - $52,560
5,498 New
5,498 $48,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email